VEGFA and neoplasm: Mast cells present in the tumour microenvironment secrete IL-17 proinflammatory cytokine, enhance NF-KB and AP-1 activity, inhibit NK and T cells, and promote angiogenesis by the production of vascular endothelial growth factor (VEGF).